North America Checkpoint Inhibitors Market was worth USD 1.82 billion in 2016 and is expected to reach USD 6.22 billion by 2021 with a CAGR of 27.8 %.
Checkpoint Inhibitors are drugs which blocks certain proteins produced by immune system or cancer cells. These proteins help cancer cells escape the immune system but by blocking these proteins immune system is able to kill cancer cells better. This is a method of treatment available in Immunotherapy.
